Literature DB >> 19918245

Peripheral neuropeptide Y Y1 receptors regulate lipid oxidation and fat accretion.

L Zhang1, L Macia, N Turner, R F Enriquez, S J Riepler, A D Nguyen, S Lin, N J Lee, Y C Shi, E Yulyaningsih, K Slack, P A Baldock, H Herzog, A Sainsbury.   

Abstract

OBJECTIVE: Neuropeptide Y and its Y receptors are important players in the regulation of energy homeostasis. However, while their functions in feeding regulation are well recognized, functions in other critical aspects of energy homeostasis are largely unknown. To investigate the function of Y1 receptors in the regulation of energy homeostasis, we examined energy expenditure, physical activity, body composition, oxidative fuel selection and mitochondrial oxidative capacity in germline Y1(-/-) mice as well as in a conditional Y1-receptor-knockdown model in which Y1 receptors were knocked down in peripheral tissues of adult mice.
RESULTS: Germline Y1(-/-) mice of both genders not only exhibit a decreased respiratory exchange ratio, indicative of increased lipid oxidation, but interestingly also develop late-onset obesity. However, the increased lipid oxidation is a primary effect of Y1 deletion rather than secondary to increased adiposity, as young Y1(-/-) mice are lean and show the same effect. The mechanism behind this is likely because of increased liver and muscle protein levels of carnitine palmitoyltransferase-1 (CPT-1) and maximal activity of key enzymes involved in beta-oxidation; beta-hydroxyacyl CoA dehydrogenase (betaHAD) and medium-chain acyl-CoA dehydrogenase (MCAD), leading to increased mitochondrial capacity for fatty acid transport and oxidation. These effects are controlled by peripheral Y1-receptor signalling, as adult-onset conditional Y1 knockdown in peripheral tissues also leads to increased lipid oxidation, liver CPT-1 levels and betaHAD activity. Importantly, these mice are resistant to diet-induced obesity.
CONCLUSIONS: This work shows the primary function of peripheral Y1 receptors in the regulation of oxidative fuel selection and adiposity, opening up new avenues for anti-obesity treatments by targeting energy utilization in peripheral tissues rather than suppressing appetite by central effects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19918245     DOI: 10.1038/ijo.2009.232

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  19 in total

Review 1.  Osteoblastic Actions of the Neuropeptide Y System to Regulate Bone and Energy Homeostasis.

Authors:  Harry Horsnell; Paul A Baldock
Journal:  Curr Osteoporos Rep       Date:  2016-02       Impact factor: 5.096

2.  Synergistic effects of genetic beta cell dysfunction and maternal glucose intolerance on offspring metabolic phenotype in mice.

Authors:  S M Lau; S Lin; R A Stokes; K Cheng; P A Baldock; R F Enriquez; M McLean; N W Cheung; A Sainsbury; F J Gonzalez; H Herzog; J E Gunton
Journal:  Diabetologia       Date:  2010-12-22       Impact factor: 10.122

3.  NPY receptors as potential targets for anti-obesity drug development.

Authors:  Ernie Yulyaningsih; Lei Zhang; Herbert Herzog; Amanda Sainsbury
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

4.  Skeletal phenotype of the neuropeptide Y knockout mouse.

Authors:  Natalie K Y Wee; Benjamin P Sinder; Sanja Novak; Xi Wang; Chris Stoddard; Brya G Matthews; Ivo Kalajzic
Journal:  Neuropeptides       Date:  2018-11-30       Impact factor: 3.286

5.  Micellar nanomedicine of human neuropeptide Y.

Authors:  Antonina Kuzmis; Sok Bee Lim; Esha Desai; Eunjung Jeon; Bao-Shiang Lee; Israel Rubinstein; Hayat Onyüksel
Journal:  Nanomedicine       Date:  2011-01-25       Impact factor: 5.307

6.  Macrophage inhibitory cytokine 1 (MIC-1/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets.

Authors:  Laurence Macia; Vicky Wang-Wei Tsai; Amy D Nguyen; Heiko Johnen; Tamara Kuffner; Yan-Chuan Shi; Shu Lin; Herbert Herzog; David A Brown; Samuel N Breit; Amanda Sainsbury
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

7.  Y1 and Y5 receptors are both required for the regulation of food intake and energy homeostasis in mice.

Authors:  Amy D Nguyen; Natalie F Mitchell; Shu Lin; Laurence Macia; Ernie Yulyaningsih; Paul A Baldock; Ronaldo F Enriquez; Lei Zhang; Yan-Chuan Shi; Serge Zolotukhin; Herbert Herzog; Amanda Sainsbury
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

Review 8.  Recent Advances in Studies on the Role of Neuroendocrine Disorders in Obstructive Sleep Apnea-Hypopnea Syndrome-Related Atherosclerosis.

Authors:  Wanda Wang; Yanli Zheng; Meimei Li; Shu Lin; Huili Lin
Journal:  Nat Sci Sleep       Date:  2021-07-27

9.  Diet-induced obesity in mice overexpressing neuropeptide y in noradrenergic neurons.

Authors:  Suvi T Ruohonen; Laura H Vähätalo; Eriika Savontaus
Journal:  Int J Pept       Date:  2012-10-18

10.  Neuropeptide Y in the noradrenergic neurons induces the development of cardiometabolic diseases in a transgenic mouse model.

Authors:  Suvi T Ruohonen; Ullamari Pesonen; Eriika Savontaus
Journal:  Indian J Endocrinol Metab       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.